Preparation of Nanosized Pharmaceutical Formulations by Dual Centrifugation.
dual asymmetric centrifugation
dual centrifugation
emulsions
homogenization
lipid nanoparticles
liposomes
nanomilling
pharmaceutical nanotechnology
polymersomes
solid lipid nanoparticles
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
received:
13
09
2023
revised:
16
10
2023
accepted:
23
10
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Dual centrifugation (DC) is an innovative in-vial homogenization and in-vial nanomilling technique that has been in use for the preparation of liposomes for more than one decade. Since then, DC has continuously been developed for preparing various liposomes and other lipid nanoparticles including emulsions and solid lipid nanoparticles (SLNs) as well as polymersomes and nanocrystals. Improvements in equipment technology have been achieved over the past decade, so that DC is now on its way to becoming the
Identifiants
pubmed: 38004385
pii: ph16111519
doi: 10.3390/ph16111519
pmc: PMC10675754
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Biomacromolecules. 2016 Oct 10;17(10):3305-3317
pubmed: 27673444
Biomacromolecules. 2015 Oct 12;16(10):3103-11
pubmed: 26324124
Int J Pharm. 2019 Dec 15;572:118753
pubmed: 31678380
Int J Pharm. 2019 Feb 25;557:1-8
pubmed: 30572079
Int J Nanomedicine. 2022 Aug 25;17:3673-3690
pubmed: 36046838
Lipids Health Dis. 2015 Jul 11;14:69
pubmed: 26162894
Eur J Pharm Sci. 2022 Oct 1;177:106267
pubmed: 35872073
Eur J Pharm Biopharm. 2015 May;92:171-9
pubmed: 25766272
J Pharm Sci. 2014 Dec;103(12):3985-3993
pubmed: 25332052
Biochim Biophys Acta. 1986 Jun 13;858(1):161-8
pubmed: 3707960
Molecules. 2021 Mar 08;26(5):
pubmed: 33800445
Int J Pharm. 2017 Jun 30;526(1-2):538-546
pubmed: 28506801
Pharmaceutics. 2023 Feb 20;15(2):
pubmed: 36840028
Small Methods. 2022 Dec;6(12):e2201001
pubmed: 36284470
Adv Drug Deliv Rev. 2011 Mar 18;63(3):131-5
pubmed: 20304019
Int J Pharm. 2020 Apr 15;579:119087
pubmed: 32213299
Biomacromolecules. 2019 Aug 12;20(8):2989-2999
pubmed: 31268685
Pharm Res. 2011 Sep;28(9):2261-72
pubmed: 21594716
Int J Pharm. 2022 Nov 25;628:122313
pubmed: 36272513
Int J Pharm. 2022 Mar 25;616:121536
pubmed: 35124120
Eur J Pharm Biopharm. 2022 Jul;176:75-86
pubmed: 35598769
Pharm Res. 2022 May;39(5):949-961
pubmed: 35552985
Cancer Chemother Pharmacol. 2002 May;49(5):356-66
pubmed: 11976829
ACS Nano. 2018 Aug 28;12(8):8646-8661
pubmed: 30081622
Int J Pharm. 2017 Sep 15;530(1-2):79-88
pubmed: 28733242
Sci Rep. 2017 Sep 21;7(1):12045
pubmed: 28935923
J Pharm Sci. 2017 Apr;106(4):968-972
pubmed: 28041969
Cells. 2020 Sep 29;9(10):
pubmed: 33003620
Int J Pharm. 2023 Nov 5;646:123455
pubmed: 37776963
Eur J Pharm Biopharm. 2019 Sep;142:61-69
pubmed: 31195130
Pharmaceutics. 2021 Dec 15;13(12):
pubmed: 34959444
J Mol Biol. 1964 May;8:660-8
pubmed: 14187392
Biochim Biophys Acta. 1985 Jan 10;812(1):55-65
pubmed: 23008845
Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
pubmed: 2946403
J Pharm Biomed Anal. 2021 Jul 15;201:114120
pubmed: 33991808
Pharmaceutics. 2022 Sep 07;14(9):
pubmed: 36145639
Biomacromolecules. 2014 Jul 14;15(7):2440-8
pubmed: 24805163
Lipids Health Dis. 2022 Sep 24;21(1):91
pubmed: 36153592
Chemistry. 2016 Aug 8;22(33):11578-82
pubmed: 27403892
Int J Pharm. 2013 Apr 15;447(1-2):31-7
pubmed: 23454573
Pain. 2018 Jul;159(7):1224-1234
pubmed: 29533388
J Control Release. 2010 Mar 19;142(3):319-25
pubmed: 19925833
J Control Release. 2012 Apr 30;159(2):281-9
pubmed: 22227023
Eur J Pharm Sci. 2023 May 1;184:106417
pubmed: 36870578
J Liposome Res. 2010 Sep;20(3):228-43
pubmed: 19899957
Int J Pharm. 2019 Jun 30;565:187-198
pubmed: 31063837
Molecules. 2020 Sep 27;25(19):
pubmed: 32992540
Beilstein J Org Chem. 2021 Oct 21;17:2621-2628
pubmed: 34760028
Macromol Rapid Commun. 2016 Jan;37(1):60-66
pubmed: 26480295
Pharmaceutics. 2022 Jul 22;14(8):
pubmed: 35893783
Macromol Biosci. 2017 Oct;17(10):
pubmed: 28759159
Pharmaceutics. 2015 Apr 01;7(2):27-42
pubmed: 25835091
Biochim Biophys Acta. 1973 Apr 16;298(4):1015-9
pubmed: 4738145
BMC Musculoskelet Disord. 2015 Apr 10;16:82
pubmed: 25888096
Eur J Pharm Sci. 2017 Jan 15;97:192-199
pubmed: 27866016
Nat Struct Mol Biol. 2020 Oct;27(10):959-966
pubmed: 32908316
J Control Release. 2008 Jan 4;125(1):16-24
pubmed: 18023907
Pharmaceutics. 2022 Nov 28;14(12):
pubmed: 36559123
Int J Nanomedicine. 2021 Nov 03;16:7417-7432
pubmed: 34764648
AAPS PharmSciTech. 2020 Oct 2;21(7):265
pubmed: 33006045
Int J Pharm X. 2021 Jun 05;3:100085
pubmed: 34159313
Int J Nanomedicine. 2022 Oct 31;17:5081-5097
pubmed: 36340183
Pharmaceutics. 2021 Nov 30;13(12):
pubmed: 34959327
Int J Pharm. 2016 Nov 30;514(1):150-159
pubmed: 27863659
Int J Pharm. 2016 Oct 15;512(1):87-95
pubmed: 27553779
Int J Pharm. 2014 Sep 10;472(1-2):48-55
pubmed: 24914829
Drug Dev Ind Pharm. 2016 Sep;42(9):1375-83
pubmed: 26710826
J Control Release. 2009 Apr 2;135(1):80-8
pubmed: 19124051
Nucleic Acids Res. 2007;35(18):e124
pubmed: 17890733
Eur J Pharm Biopharm. 2013 May;84(1):172-82
pubmed: 23275113
J Control Release. 2023 Feb;354:851-868
pubmed: 36681282
J Pharm Pharmacol. 2020 Oct;72(10):1328-1340
pubmed: 32671856
FEBS Lett. 1979 Mar 1;99(1):210-4
pubmed: 437128
RNA Biol. 2022 Jan;19(1):78-88
pubmed: 34965175
Eur J Pharm Biopharm. 2020 Aug;153:158-167
pubmed: 32522680
Int J Pharm. 2011 Mar 15;406(1-2):145-52
pubmed: 21185926
Eur J Pharm Biopharm. 2016 Jun;103:159-166
pubmed: 27049970
Biochim Biophys Acta. 1984 Aug 22;775(2):169-74
pubmed: 6466665
Sci Rep. 2016 Sep 21;6:33791
pubmed: 27650487
Biomaterials. 2015 Jun;53:137-48
pubmed: 25890714
Biochim Biophys Acta. 1985 Sep 10;818(3):343-51
pubmed: 2412582
Nat Commun. 2021 Oct 13;12(1):5981
pubmed: 34645812
Eur J Pharm Sci. 2017 Oct 15;108:111-118
pubmed: 28716758
Cells. 2020 Sep 05;9(9):
pubmed: 32899484
Drug Des Devel Ther. 2020 May 12;14:1825-1836
pubmed: 32494124